Renal Failure
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q1 | 82.1% | 0.946 | Q1 | 82.4% |
| 2024 | 3.0 | Q1 | 76.9% | 0.840 | Q1 | 79.4% |
| 2023 | 3.0 | Q1 | 77.8% | 0.727 | Q2 | 76.8% |
| 2022 | 3.0 | Q2 | 73.6% | 0.654 | Q2 | 74.7% |
| 2021 | 3.2 | Q2 | 71.4% | 0.593 | Q2 | 72.5% |
| 2020 | — | — | 0.674 | Q2 | 75.1% | |
| 2019 | — | — | 0.571 | Q2 | 71.2% | |
| 2018 | — | — | 0.591 | Q2 | 70.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1525-6049
ISSN
0886-022X
region
Western Europe
coverage
1976-1985, 1987, 1989-2026